JP2007509651A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007509651A5 JP2007509651A5 JP2006536856A JP2006536856A JP2007509651A5 JP 2007509651 A5 JP2007509651 A5 JP 2007509651A5 JP 2006536856 A JP2006536856 A JP 2006536856A JP 2006536856 A JP2006536856 A JP 2006536856A JP 2007509651 A5 JP2007509651 A5 JP 2007509651A5
- Authority
- JP
- Japan
- Prior art keywords
- graft
- embolic material
- kit
- inflatable
- distal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000463 material Substances 0.000 claims description 149
- 230000003073 embolic effect Effects 0.000 claims description 119
- 239000012530 fluid Substances 0.000 claims description 27
- 230000017531 blood circulation Effects 0.000 claims description 23
- 125000004386 diacrylate group Chemical group 0.000 claims description 20
- 239000002202 Polyethylene glycol Substances 0.000 claims description 19
- 229920001223 polyethylene glycol Polymers 0.000 claims description 19
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 claims description 18
- 239000000872 buffer Substances 0.000 claims description 17
- 239000006172 buffering agent Substances 0.000 claims description 11
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 claims description 11
- 238000004891 communication Methods 0.000 claims description 10
- DKIDEFUBRARXTE-UHFFFAOYSA-N 3-mercaptopropanoic acid Chemical compound OC(=O)CCS DKIDEFUBRARXTE-UHFFFAOYSA-N 0.000 claims description 9
- 108010008488 Glycylglycine Proteins 0.000 claims description 9
- 210000004204 blood vessel Anatomy 0.000 claims description 9
- 229940043257 glycylglycine Drugs 0.000 claims description 9
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 6
- 239000007995 HEPES buffer Substances 0.000 claims description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- 239000000560 biocompatible material Substances 0.000 claims description 3
- 238000000151 deposition Methods 0.000 claims description 3
- 239000007999 glycylglycine buffer Substances 0.000 claims description 3
- PMNLUUOXGOOLSP-UHFFFAOYSA-M 2-sulfanylpropanoate Chemical compound CC(S)C([O-])=O PMNLUUOXGOOLSP-UHFFFAOYSA-M 0.000 claims 2
- 238000000034 method Methods 0.000 description 41
- 206010002329 Aneurysm Diseases 0.000 description 36
- 208000001750 Endoleak Diseases 0.000 description 31
- 206010064396 Stent-graft endoleak Diseases 0.000 description 17
- 210000000709 aorta Anatomy 0.000 description 16
- 208000007474 aortic aneurysm Diseases 0.000 description 13
- 208000002223 abdominal aortic aneurysm Diseases 0.000 description 12
- 210000001367 artery Anatomy 0.000 description 12
- 239000007788 liquid Substances 0.000 description 9
- 230000010412 perfusion Effects 0.000 description 9
- 229920000671 polyethylene glycol diacrylate Polymers 0.000 description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- 238000002347 injection Methods 0.000 description 8
- 239000007924 injection Substances 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 229920000642 polymer Polymers 0.000 description 8
- 230000008439 repair process Effects 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 238000007789 sealing Methods 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 210000003090 iliac artery Anatomy 0.000 description 6
- 206010058178 Aortic occlusion Diseases 0.000 description 5
- 238000002594 fluoroscopy Methods 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 210000004249 mesenteric artery inferior Anatomy 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 210000002254 renal artery Anatomy 0.000 description 5
- 238000001356 surgical procedure Methods 0.000 description 5
- -1 TRUFILL Chemical compound 0.000 description 4
- 201000008982 Thoracic Aortic Aneurysm Diseases 0.000 description 4
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 4
- 238000002591 computed tomography Methods 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 210000005166 vasculature Anatomy 0.000 description 4
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 3
- 238000006845 Michael addition reaction Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 210000001363 mesenteric artery superior Anatomy 0.000 description 3
- 229910052715 tantalum Inorganic materials 0.000 description 3
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- 208000004717 Ruptured Aneurysm Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 210000003484 anatomy Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000004715 ethylene vinyl alcohol Substances 0.000 description 2
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 description 2
- 208000003457 familial thoracic 1 aortic aneurysm Diseases 0.000 description 2
- 210000001105 femoral artery Anatomy 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 230000003836 peripheral circulation Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000007711 solidification Methods 0.000 description 2
- 230000008023 solidification Effects 0.000 description 2
- 239000002195 soluble material Substances 0.000 description 2
- 230000009974 thixotropic effect Effects 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- YIIPOGLCNUDSBG-UHFFFAOYSA-N 2,2-bis(hydroxymethyl)propane-1,3-diol;3-sulfanylpropanoic acid Chemical compound OC(=O)CCS.OC(=O)CCS.OC(=O)CCS.OC(=O)CCS.OCC(CO)(CO)CO YIIPOGLCNUDSBG-UHFFFAOYSA-N 0.000 description 1
- GTELLNMUWNJXMQ-UHFFFAOYSA-N 2-ethyl-2-(hydroxymethyl)propane-1,3-diol;prop-2-enoic acid Chemical class OC(=O)C=C.OC(=O)C=C.OC(=O)C=C.CCC(CO)(CO)CO GTELLNMUWNJXMQ-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 229920001651 Cyanoacrylate Polymers 0.000 description 1
- 206010014513 Embolism arterial Diseases 0.000 description 1
- 238000012276 Endovascular treatment Methods 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000010108 arterial embolization Effects 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 239000006177 biological buffer Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 210000002434 celiac artery Anatomy 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000002716 delivery method Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000013161 embolization procedure Methods 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-N ethanesulfonic acid Chemical compound CCS(O)(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-N 0.000 description 1
- 238000005429 filling process Methods 0.000 description 1
- 238000005243 fluidization Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- RZXDTJIXPSCHCI-UHFFFAOYSA-N hexa-1,5-diene-2,5-diol Chemical compound OC(=C)CCC(O)=C RZXDTJIXPSCHCI-UHFFFAOYSA-N 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 230000003447 ipsilateral effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000003975 mesenteric artery Anatomy 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 238000005935 nucleophilic addition reaction Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 238000000710 polymer precipitation Methods 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 239000013008 thixotropic agent Substances 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/691,849 US20050090804A1 (en) | 2003-10-22 | 2003-10-22 | Endoluminal prosthesis endoleak management |
| PCT/US2004/035179 WO2005039442A2 (en) | 2003-10-22 | 2004-10-21 | Endoluminal prosthesis endoleak management |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007509651A JP2007509651A (ja) | 2007-04-19 |
| JP2007509651A5 true JP2007509651A5 (cg-RX-API-DMAC7.html) | 2010-10-07 |
Family
ID=34521952
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006536856A Ceased JP2007509651A (ja) | 2003-10-22 | 2004-10-21 | 管腔内補綴のエンドリーク管理 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20050090804A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1691881A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2007509651A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2542890A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005039442A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040138734A1 (en) * | 2001-04-11 | 2004-07-15 | Trivascular, Inc. | Delivery system and method for bifurcated graft |
| US20100016943A1 (en) * | 2001-12-20 | 2010-01-21 | Trivascular2, Inc. | Method of delivering advanced endovascular graft |
| WO2004026183A2 (en) * | 2002-09-20 | 2004-04-01 | Nellix, Inc. | Stent-graft with positioning anchor |
| US20070078506A1 (en) * | 2004-04-13 | 2007-04-05 | Mccormick Paul | Method and apparatus for decompressing aneurysms |
| WO2005099807A2 (en) * | 2004-04-13 | 2005-10-27 | Endologix, Inc. | Method and apparatus for decompressing aneurysms |
| US8048145B2 (en) | 2004-07-22 | 2011-11-01 | Endologix, Inc. | Graft systems having filling structures supported by scaffolds and methods for their use |
| AU2006269419A1 (en) | 2005-07-07 | 2007-01-18 | Nellix, Inc. | Systems and methods for endovascular aneurysm treatment |
| US8216297B2 (en) * | 2006-08-14 | 2012-07-10 | Trivascular, Inc. | Dual chamber cuff structure |
| US20080188923A1 (en) * | 2007-02-01 | 2008-08-07 | Jack Fa-De Chu | Endovascular devices to protect aneurysmal wall |
| US20080228259A1 (en) * | 2007-03-16 | 2008-09-18 | Jack Fa-De Chu | Endovascular devices and methods to protect aneurysmal wall |
| CA2697364C (en) | 2007-08-23 | 2017-10-17 | Direct Flow Medical, Inc. | Translumenally implantable heart valve with formed in place support |
| US8066755B2 (en) | 2007-09-26 | 2011-11-29 | Trivascular, Inc. | System and method of pivoted stent deployment |
| US8663309B2 (en) | 2007-09-26 | 2014-03-04 | Trivascular, Inc. | Asymmetric stent apparatus and method |
| US8226701B2 (en) | 2007-09-26 | 2012-07-24 | Trivascular, Inc. | Stent and delivery system for deployment thereof |
| JP2010540190A (ja) | 2007-10-04 | 2010-12-24 | トリバスキュラー・インコーポレイテッド | 低プロファイル経皮的送達のためのモジュラー式血管グラフト |
| US8328861B2 (en) | 2007-11-16 | 2012-12-11 | Trivascular, Inc. | Delivery system and method for bifurcated graft |
| US8083789B2 (en) | 2007-11-16 | 2011-12-27 | Trivascular, Inc. | Securement assembly and method for expandable endovascular device |
| EP2278939B1 (en) | 2008-04-25 | 2021-04-14 | Endologix LLC | Stent graft delivery system |
| JP2011522615A (ja) * | 2008-06-04 | 2011-08-04 | ネリックス・インコーポレーテッド | 封止装置および使用方法 |
| WO2010127305A2 (en) | 2009-05-01 | 2010-11-04 | Endologix, Inc. | Percutaneous method and device to treat dissections |
| US10772717B2 (en) | 2009-05-01 | 2020-09-15 | Endologix, Inc. | Percutaneous method and device to treat dissections |
| JP5588511B2 (ja) | 2009-07-27 | 2014-09-10 | エンドロジックス、インク | ステントグラフト |
| US20110276078A1 (en) | 2009-12-30 | 2011-11-10 | Nellix, Inc. | Filling structure for a graft system and methods of use |
| US20110218609A1 (en) * | 2010-02-10 | 2011-09-08 | Trivascular, Inc. | Fill tube manifold and delivery methods for endovascular graft |
| WO2011117736A2 (en) | 2010-03-22 | 2011-09-29 | Scitech Produtos Medicos Ltda | Endoprosthesis and delivery system for delivering the endoprosthesis within a vessel of a patient |
| US9603708B2 (en) | 2010-05-19 | 2017-03-28 | Dfm, Llc | Low crossing profile delivery catheter for cardiovascular prosthetic implant |
| WO2012068298A1 (en) | 2010-11-17 | 2012-05-24 | Endologix, Inc. | Devices and methods to treat vascular dissections |
| US8801768B2 (en) | 2011-01-21 | 2014-08-12 | Endologix, Inc. | Graft systems having semi-permeable filling structures and methods for their use |
| US8911468B2 (en) * | 2011-01-31 | 2014-12-16 | Vatrix Medical, Inc. | Devices, therapeutic compositions and corresponding percutaneous treatment methods for aortic dissection |
| CN103648437B (zh) | 2011-04-06 | 2016-05-04 | 恩朵罗杰克斯国际控股有限公司 | 用于血管动脉瘤治疗的方法和系统 |
| JP2014522263A (ja) | 2011-05-11 | 2014-09-04 | マイクロベンション インコーポレイテッド | 内腔を閉塞するためのデバイス |
| US8978448B2 (en) | 2011-10-11 | 2015-03-17 | Trivascular, Inc. | In vitro testing of endovascular device |
| WO2013074921A2 (en) | 2011-11-17 | 2013-05-23 | Smouse Harry Robinson | Methods and apparatus for treating a type 2 endoleak from within an endoluminal stent graft |
| US8992595B2 (en) | 2012-04-04 | 2015-03-31 | Trivascular, Inc. | Durable stent graft with tapered struts and stable delivery methods and devices |
| US9498363B2 (en) | 2012-04-06 | 2016-11-22 | Trivascular, Inc. | Delivery catheter for endovascular device |
| US9445897B2 (en) | 2012-05-01 | 2016-09-20 | Direct Flow Medical, Inc. | Prosthetic implant delivery device with introducer catheter |
| US10052107B2 (en) | 2012-06-25 | 2018-08-21 | Arsenal Medical, Inc. | Systems and methods for the treatment of aneurysms |
| EP2968692B8 (en) | 2013-03-14 | 2021-02-24 | Endologix LLC | Method for forming materials in situ within a medical device |
| US11123205B2 (en) * | 2013-09-24 | 2021-09-21 | Trivascular, Inc. | Tandem modular endograft |
| CN106232059B (zh) * | 2014-03-10 | 2018-11-23 | 曲瓦斯库勒股份有限公司 | 用于主动脉应用的可充胀的封堵丝球囊 |
| US10849774B2 (en) | 2014-10-23 | 2020-12-01 | Trivascular, Inc. | Stent graft delivery system with access conduit |
| NL2015809B1 (en) * | 2015-11-18 | 2017-06-02 | Car Holding B V | Composition for use in the treatment or prevention of endoleak. |
| US20180369446A1 (en) | 2015-11-18 | 2018-12-27 | Car Holding B.V. | Curable silicone (pre-) polymer composition comprising a contrast agent |
| WO2018045097A1 (en) * | 2016-08-31 | 2018-03-08 | Endologix, Inc. | Systems and methods with stent and filling structure |
Family Cites Families (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3540431A (en) * | 1968-04-04 | 1970-11-17 | Kazi Mobin Uddin | Collapsible filter for fluid flowing in closed passageway |
| US3653959A (en) * | 1970-04-14 | 1972-04-04 | Grace W R & Co | Encapsulating and potting composition and process |
| US4245623A (en) * | 1978-06-06 | 1981-01-20 | Erb Robert A | Method and apparatus for the hysteroscopic non-surgical sterilization of females |
| US4708718A (en) * | 1985-07-02 | 1987-11-24 | Target Therapeutics | Hyperthermic treatment of tumors |
| US5059766A (en) * | 1985-10-25 | 1991-10-22 | Gilliland Malcolm T | Method and apparatus for improved arc striking |
| EP0257091B1 (en) * | 1986-02-24 | 1993-07-28 | Robert E. Fischell | An intravascular stent and percutaneous insertion system |
| US4795741A (en) * | 1987-05-06 | 1989-01-03 | Biomatrix, Inc. | Compositions for therapeutic percutaneous embolization and the use thereof |
| US5059211A (en) * | 1987-06-25 | 1991-10-22 | Duke University | Absorbable vascular stent |
| FR2629463B1 (fr) * | 1988-04-01 | 1990-12-14 | Rhone Poulenc Chimie | Procede de preparation de polymeres a base de bore et d'azote precurseurs de nitrure de bore |
| US5203779A (en) * | 1989-03-17 | 1993-04-20 | Schott Glaswerke | Catheter system for vessel recanalization in the human body |
| DE69114782T2 (de) * | 1990-08-08 | 1996-04-18 | Takeda Chemical Industries Ltd | Intravaskulär embolisierendes Mittel mit Gehalt an einem die Angiogenesis hemmenden Stoff. |
| US5231562A (en) * | 1991-01-02 | 1993-07-27 | Lawrence Pierce | Desk top wire management apparatus |
| JP3356447B2 (ja) * | 1991-10-16 | 2002-12-16 | テルモ株式会社 | 乾燥高分子ゲルからなる血管病変塞栓材料 |
| US5306294A (en) * | 1992-08-05 | 1994-04-26 | Ultrasonic Sensing And Monitoring Systems, Inc. | Stent construction of rolled configuration |
| JPH078298A (ja) * | 1993-06-28 | 1995-01-13 | Nippon Shoji Kk | アンチトロンビンｉｉｉ活性の測定方法および該測定用試薬キット |
| US5618528A (en) * | 1994-02-28 | 1997-04-08 | Sterling Winthrop Inc. | Biologically compatible linear block copolymers of polyalkylene oxide and peptide units |
| US5554181A (en) * | 1994-05-04 | 1996-09-10 | Regents Of The University Of Minnesota | Stent |
| JP2535785B2 (ja) * | 1994-06-03 | 1996-09-18 | 工業技術院長 | 血管塞栓剤 |
| US5824041A (en) * | 1994-06-08 | 1998-10-20 | Medtronic, Inc. | Apparatus and methods for placement and repositioning of intraluminal prostheses |
| US5788707A (en) * | 1995-06-07 | 1998-08-04 | Scimed Life Systems, Inc. | Pull back sleeve system with compression resistant inner shaft |
| US5785679A (en) * | 1995-07-19 | 1998-07-28 | Endotex Interventional Systems, Inc. | Methods and apparatus for treating aneurysms and arterio-venous fistulas |
| US5667767A (en) * | 1995-07-27 | 1997-09-16 | Micro Therapeutics, Inc. | Compositions for use in embolizing blood vessels |
| US5580568A (en) * | 1995-07-27 | 1996-12-03 | Micro Therapeutics, Inc. | Cellulose diacetate compositions for use in embolizing blood vessels |
| US5888546A (en) * | 1995-08-28 | 1999-03-30 | The Regents Of The University Of California | Embolic material for endovascular occlusion of abnormal vasculature and method for using the same |
| US5749894A (en) * | 1996-01-18 | 1998-05-12 | Target Therapeutics, Inc. | Aneurysm closure method |
| US5702361A (en) * | 1996-01-31 | 1997-12-30 | Micro Therapeutics, Inc. | Method for embolizing blood vessels |
| CN1213316A (zh) * | 1996-03-11 | 1999-04-07 | 富克尔公司 | 放射性核素及放射性医药品的聚合物输送 |
| US20010029349A1 (en) * | 1996-04-12 | 2001-10-11 | Boris Leschinsky | Method and apparatus for treating aneurysms |
| JP2001509133A (ja) * | 1996-05-31 | 2001-07-10 | マイクロ セラピューティクス インコーポレーテッド | 閉塞化血管における使用のための組成物 |
| US5695480A (en) * | 1996-07-29 | 1997-12-09 | Micro Therapeutics, Inc. | Embolizing compositions |
| US5830178A (en) * | 1996-10-11 | 1998-11-03 | Micro Therapeutics, Inc. | Methods for embolizing vascular sites with an emboilizing composition comprising dimethylsulfoxide |
| US5925683A (en) * | 1996-10-17 | 1999-07-20 | Target Therapeutics, Inc. | Liquid embolic agents |
| US6316522B1 (en) * | 1997-08-18 | 2001-11-13 | Scimed Life Systems, Inc. | Bioresorbable hydrogel compositions for implantable prostheses |
| US6476069B2 (en) * | 1997-09-11 | 2002-11-05 | Provasis Therapeutics Inc. | Compositions for creating embolic agents and uses thereof |
| US6511468B1 (en) * | 1997-10-17 | 2003-01-28 | Micro Therapeutics, Inc. | Device and method for controlling injection of liquid embolic composition |
| US6146373A (en) * | 1997-10-17 | 2000-11-14 | Micro Therapeutics, Inc. | Catheter system and method for injection of a liquid embolic composition and a solidification agent |
| US6015541A (en) * | 1997-11-03 | 2000-01-18 | Micro Therapeutics, Inc. | Radioactive embolizing compositions |
| US6395019B2 (en) * | 1998-02-09 | 2002-05-28 | Trivascular, Inc. | Endovascular graft |
| US6152943A (en) * | 1998-08-14 | 2000-11-28 | Incept Llc | Methods and apparatus for intraluminal deposition of hydrogels |
| US6238335B1 (en) * | 1998-12-11 | 2001-05-29 | Enteric Medical Technologies, Inc. | Method for treating gastroesophageal reflux disease and apparatus for use therewith |
| US6958212B1 (en) * | 1999-02-01 | 2005-10-25 | Eidgenossische Technische Hochschule Zurich | Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
| EP1181323B1 (en) * | 1999-02-01 | 2011-06-29 | Eidgenössische Technische Hochschule Zürich | Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups |
| US6303100B1 (en) * | 1999-03-19 | 2001-10-16 | Micro Therapeutics, Inc. | Methods for inhibiting the formation of potential endoleaks associated with endovascular repair of abdominal aortic aneurysms |
| US6203779B1 (en) * | 1999-03-19 | 2001-03-20 | Charlie Ricci | Methods for treating endoleaks during endovascular repair of abdominal aortic aneurysms |
| US6428576B1 (en) * | 1999-04-16 | 2002-08-06 | Endospine, Ltd. | System for repairing inter-vertebral discs |
| EP1180003B1 (en) * | 1999-05-20 | 2008-01-16 | Boston Scientific Limited | Stent delivery system with nested stabilizer |
| CA2371321C (en) * | 1999-05-21 | 2008-12-23 | Micro Therapeutics, Inc. | Novel high viscosity embolizing compositions |
| EP1180051A4 (en) * | 1999-05-21 | 2004-06-30 | Micro Therapeutics Inc | METHODS FOR EMBOLIZING BLOOD VESSELS WITH AN EMBOLIZING CONNECTION |
| US6398802B1 (en) * | 1999-06-21 | 2002-06-04 | Scimed Life Systems, Inc. | Low profile delivery system for stent and graft deployment |
| AU7084300A (en) * | 1999-08-27 | 2001-03-26 | Cohesion Technologies, Inc. | Compositions that form interpenetrating polymer networks for use as high strength medical sealants |
| US6280465B1 (en) * | 1999-12-30 | 2001-08-28 | Advanced Cardiovascular Systems, Inc. | Apparatus and method for delivering a self-expanding stent on a guide wire |
| US6602280B2 (en) * | 2000-02-02 | 2003-08-05 | Trivascular, Inc. | Delivery system and method for expandable intracorporeal device |
| US20020026217A1 (en) * | 2000-04-26 | 2002-02-28 | Steven Baker | Apparatus and method for repair of perigraft flow |
| EP1399213A4 (en) * | 2000-10-11 | 2008-03-19 | Micro Therapeutics Inc | METHOD FOR THE TREATMENT OF ANEURISMS |
| US6562064B1 (en) * | 2000-10-27 | 2003-05-13 | Vascular Architects, Inc. | Placement catheter assembly |
| US20020169497A1 (en) * | 2001-01-02 | 2002-11-14 | Petra Wholey | Endovascular stent system and method of providing aneurysm embolization |
| US6602269B2 (en) * | 2001-03-30 | 2003-08-05 | Scimed Life Systems | Embolic devices capable of in-situ reinforcement |
| US20020165593A1 (en) * | 2001-05-03 | 2002-11-07 | Reid Hayashi | Apparatus and method for aiding thrombosis through polymerization |
| US6702847B2 (en) * | 2001-06-29 | 2004-03-09 | Scimed Life Systems, Inc. | Endoluminal device with indicator member for remote detection of endoleaks and/or changes in device morphology |
| US20030014075A1 (en) * | 2001-07-16 | 2003-01-16 | Microvention, Inc. | Methods, materials and apparatus for deterring or preventing endoleaks following endovascular graft implanation |
| DE50111393D1 (de) * | 2001-12-05 | 2006-12-14 | Synthes Gmbh | Bandscheibenprothese oder nukleus-prothese |
| US7147661B2 (en) * | 2001-12-20 | 2006-12-12 | Boston Scientific Santa Rosa Corp. | Radially expandable stent |
| US7147660B2 (en) * | 2001-12-20 | 2006-12-12 | Boston Scientific Santa Rosa Corp. | Advanced endovascular graft |
| WO2004096152A2 (en) * | 2003-04-24 | 2004-11-11 | Arizona Board Of Regents | In situ gelling self-reactive materials for embolization |
| US7178978B2 (en) * | 2003-09-08 | 2007-02-20 | Boston Scientific Santa Rosa Corp., | Fluid mixing apparatus and method |
-
2003
- 2003-10-22 US US10/691,849 patent/US20050090804A1/en not_active Abandoned
-
2004
- 2004-10-21 WO PCT/US2004/035179 patent/WO2005039442A2/en not_active Ceased
- 2004-10-21 JP JP2006536856A patent/JP2007509651A/ja not_active Ceased
- 2004-10-21 CA CA002542890A patent/CA2542890A1/en not_active Abandoned
- 2004-10-21 EP EP04796213A patent/EP1691881A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007509651A5 (cg-RX-API-DMAC7.html) | ||
| JP2007509651A (ja) | 管腔内補綴のエンドリーク管理 | |
| JP5468030B2 (ja) | 膨張可能な多孔性インプラント、及び薬物送達のための方法 | |
| US11439497B2 (en) | Advanced endovascular graft | |
| US20070078506A1 (en) | Method and apparatus for decompressing aneurysms | |
| AU2009230748B2 (en) | Advanced endovascular graft | |
| JP4891240B2 (ja) | 血管内動脈瘤処置のための方法およびシステム | |
| US8133267B2 (en) | Apparatus for engrafting a blood vessel | |
| JP6784490B2 (ja) | デブランチング用大血管ステントグラフト及び使用方法 | |
| US20050245891A1 (en) | Method and apparatus for decompressing aneurysms | |
| Lazarus | Endovascular grafting for the treatment of abdominal aortic aneurysms | |
| Qu et al. | Two-year single-center experience with thoracic endovascular aortic repair using the EndoFit thoracic stent-graft | |
| Blum et al. | Abdominal aortic aneurysm repair using the Meadox/Vanguard prosthesis: Indications, implantation technique, and results | |
| Oderich et al. | Endovascular repair of TAAAs with the t-Branch multibranched stent graft | |
| WO2025264969A1 (en) | Methods and devices for treating abdominal aneurysms | |
| Kawawa et al. | Notes on the application of the Matsui-Kitamura stent-graft for endovascular repair of abdominal aortic aneurysm |